{"success":true,"data":{"pressRelease":{"id":"135275","rtpr_id":"nPnW8NNDa","ticker":"HCTI","exchange":"NASDAQ","all_tickers":["HCTI"],"title":"Healthcare Triangle, Inc. to Distribute Minority Interest of Teyame AI Holdings Inc. Common Shares in Stock Dividend Distribution to HCTI Shareholders, In Connection with its Planned Direct Listing.","author":"PR Newswire","published_at":"2026-09-03T13:05:01.641Z","article_body":"Healthcare Triangle, Inc. to Distribute Minority Interest of Teyame AI Holdings Inc. Common Shares in Stock Dividend Distribution to HCTI Shareholders, In Connection with its Planned Direct Listing.\n\nPR Newswire\n\nPLEASANTON, Calif., Sept. 3, 2026\n\nBoard of Directors Approves Stock Dividend Distribution of a Minority Interest\nof Outstanding Common Shares of Teyame AI Holdings Inc. Common Stock to\nExisting HCTI Shareholders; HCTI Signs Agreement in Connection with Planned\nDirect Listing of Teyame AI Holdings Inc. Transaction Subject to NASDAQ\nApproval\n\nPLEASANTON, Calif., Sept. 3, 2026 /PRNewswire/ -- Healthcare Triangle, Inc.\n(Nasdaq: HCTI) (\"HCTI\" or the \"Company\"), a healthcare technology company\ndelivering cloud, digital transformation, and data-driven solutions to\nhealthcare and life sciences organizations, including AI-powered customer\nengagement services delivering AI-powered customer engagement and digital\ntransformation services, today announced that it has signed a separation\nagreement (the \"Separation Agreement\") with its subsidiary Teyame AI Holdings\nInc. (\"Teyame AI Holdings\") setting forth the terms governing the planned\nseparation (the \"Separation\") of Teyame AI Holdings from HCTI. The Separation\nAgreement addresses, among other matters, the allocation of assets and\nliabilities between HCTI and Teyame AI Holdings, transition services to be\nprovided between the companies, and other terms customary for a transaction of\nthis type. In connection with the Separation, the Company has planned a direct\nlisting of Teyame AI Holding's common stock on NASDAQ (the \"Direct Listing\").\nTeyame AI Holdings holds HCTI's recently acquired AI-powered customer\nexperience businesses, Teyame 360 S.L. and Datono Mediación S.L. (together,\n\"Teyame AI\"), which HCTI acquired pursuant to a definitive share purchase\nagreement dated January 22, 2026.\n\nCompletion of the Direct Listing is subject to, among other things, review by\nthe U.S. Securities and Exchange Commission (\"SEC\") of a registration\nstatement to be filed by Teyame AI Holdings and the approval by NASDAQ of the\nDirect Listing.\n\nIn connection with the planned separation, HCTI's Board of Directors (the\n\"Board\") has approved a stock dividend pursuant to which HCTI will distribute\na Minority Interest of the outstanding shares of Teyame AI Holdings common\nstock to holders of HCTI common stock as of the record date to be prescribed\nin future filings (the \"Record Date\") upon the approval by NASDAQ of the\nDirect Listing.\n\nTHIS PRESS RELEASE IS NOT AN OFFER OF ANY SECURITIES FOR SALE.\n\nInvestors\n1-800-617-9550\nir@healthcaretriangle.com (mailto:ir@healthcaretriangle.com)\n\n \n\nView original\ncontent:https://www.prnewswire.com/news-releases/healthcare-triangle-inc-to-distribute-minority-interest-of-teyame-ai-holdings-inc-common-shares-in-stock-dividend-distribution-to-hcti-shareholders-in-connection-with-its-planned-direct-listing-302868702.html\n(https://www.prnewswire.com/news-releases/healthcare-triangle-inc-to-distribute-minority-interest-of-teyame-ai-holdings-inc-common-shares-in-stock-dividend-distribution-to-hcti-shareholders-in-connection-with-its-planned-direct-listing-302868702.html)\n\nSOURCE Healthcare Triangle, Inc.\n\n\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPnW8NNDa","title":"Healthcare Triangle, Inc. to Distribute Minority Interest of Teyame AI Holdings Inc. Common Shares in Stock Dividend Distribution to HCTI Shareholders, In Connection with its Planned Direct Listing.","author":"PR Newswire","ticker":"HCTI","created":"2026-09-03T13:05:01.641Z","tickers":["HCTI"],"exchange":"NASDAQ","article_body":"Healthcare Triangle, Inc. to Distribute Minority Interest of Teyame AI Holdings Inc. Common Shares in Stock Dividend Distribution to HCTI Shareholders, In Connection with its Planned Direct Listing.\n\nPR Newswire\n\nPLEASANTON, Calif., Sept. 3, 2026\n\nBoard of Directors Approves Stock Dividend Distribution of a Minority Interest\nof Outstanding Common Shares of Teyame AI Holdings Inc. Common Stock to\nExisting HCTI Shareholders; HCTI Signs Agreement in Connection with Planned\nDirect Listing of Teyame AI Holdings Inc. Transaction Subject to NASDAQ\nApproval\n\nPLEASANTON, Calif., Sept. 3, 2026 /PRNewswire/ -- Healthcare Triangle, Inc.\n(Nasdaq: HCTI) (\"HCTI\" or the \"Company\"), a healthcare technology company\ndelivering cloud, digital transformation, and data-driven solutions to\nhealthcare and life sciences organizations, including AI-powered customer\nengagement services delivering AI-powered customer engagement and digital\ntransformation services, today announced that it has signed a separation\nagreement (the \"Separation Agreement\") with its subsidiary Teyame AI Holdings\nInc. (\"Teyame AI Holdings\") setting forth the terms governing the planned\nseparation (the \"Separation\") of Teyame AI Holdings from HCTI. The Separation\nAgreement addresses, among other matters, the allocation of assets and\nliabilities between HCTI and Teyame AI Holdings, transition services to be\nprovided between the companies, and other terms customary for a transaction of\nthis type. In connection with the Separation, the Company has planned a direct\nlisting of Teyame AI Holding's common stock on NASDAQ (the \"Direct Listing\").\nTeyame AI Holdings holds HCTI's recently acquired AI-powered customer\nexperience businesses, Teyame 360 S.L. and Datono Mediación S.L. (together,\n\"Teyame AI\"), which HCTI acquired pursuant to a definitive share purchase\nagreement dated January 22, 2026.\n\nCompletion of the Direct Listing is subject to, among other things, review by\nthe U.S. Securities and Exchange Commission (\"SEC\") of a registration\nstatement to be filed by Teyame AI Holdings and the approval by NASDAQ of the\nDirect Listing.\n\nIn connection with the planned separation, HCTI's Board of Directors (the\n\"Board\") has approved a stock dividend pursuant to which HCTI will distribute\na Minority Interest of the outstanding shares of Teyame AI Holdings common\nstock to holders of HCTI common stock as of the record date to be prescribed\nin future filings (the \"Record Date\") upon the approval by NASDAQ of the\nDirect Listing.\n\nTHIS PRESS RELEASE IS NOT AN OFFER OF ANY SECURITIES FOR SALE.\n\nInvestors\n1-800-617-9550\nir@healthcaretriangle.com (mailto:ir@healthcaretriangle.com)\n\n \n\nView original\ncontent:https://www.prnewswire.com/news-releases/healthcare-triangle-inc-to-distribute-minority-interest-of-teyame-ai-holdings-inc-common-shares-in-stock-dividend-distribution-to-hcti-shareholders-in-connection-with-its-planned-direct-listing-302868702.html\n(https://www.prnewswire.com/news-releases/healthcare-triangle-inc-to-distribute-minority-interest-of-teyame-ai-holdings-inc-common-shares-in-stock-dividend-distribution-to-hcti-shareholders-in-connection-with-its-planned-direct-listing-302868702.html)\n\nSOURCE Healthcare Triangle, Inc.\n\n\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-09-03T13:05:01.677824058Z","server_sent_at_ms":1788440701677},"received_at":"2026-09-03T13:05:01.736Z","source_url":"https://www.prnewswire.com/news-releases/healthcare-triangle-inc-to-distribute-minority-interest-of-teyame-ai-holdings-inc-common-shares-in-stock-dividend-distribution-to-hcti-shareholders-in-connection-with-its-planned-direct-listing-302868702.html"},"analysis":{"id":"124162","press_release_id":"135275","analysis_json":{"industry":{"label":"Health Care Technology","sector":"Health Care"},"redFlags":["Separation and direct listing are conditional on SEC registration review and Nasdaq approval — no certainty of completion","No distribution ratio, record date, valuation, or timeline disclosed","Teyame AI units were acquired only in January 2026 — separation announced roughly seven months after acquisition","Only a minority interest is being distributed; HCTI retains majority ownership of Teyame AI Holdings"],"eventType":"m_and_a","narrative":"Healthcare Triangle (Nasdaq: HCTI) signed a separation agreement with its subsidiary Teyame AI Holdings Inc., setting the terms for spinning off the unit via a planned direct listing of Teyame shares on Nasdaq.\n\nIn connection with the separation, HCTI's board approved a stock dividend under which HCTI shareholders of record will receive a minority interest of Teyame AI Holdings common stock, with the record date to be set in future filings.\n\nTeyame AI Holdings contains the AI-powered customer experience businesses Teyame 360 S.L. and Datono Mediación S.L., which HCTI acquired under a January 22, 2026 share purchase agreement. Completion is subject to SEC review of a registration statement and Nasdaq approval; no distribution ratio, valuation, or timeline was disclosed.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"Micro-cap HCTI to spin off and directly list its Teyame AI unit with a stock dividend to holders — watch for record date, distribution ratio, and registration details in future filings."},"keyFigures":{},"quotedText":"Completion of the Direct Listing is subject to, among other things, review by\nthe U.S. Securities and Exchange Commission (\"SEC\") of a registration\nstatement to be filed by Teyame AI Holdings and the approval by NASDAQ of the\nDirect Listing.","namedEntities":{"people":[],"products":["Teyame AI"],"companies":[{"name":"Healthcare Triangle, Inc.","ticker":"HCTI","relationship":"filer/parent company executing the separation"},{"name":"Teyame AI Holdings Inc.","relationship":"subsidiary to be separated and directly listed on Nasdaq"},{"name":"Teyame 360 S.L.","relationship":"AI-powered customer experience business held under Teyame AI Holdings"},{"name":"Datono Mediación S.L.","relationship":"AI-powered customer experience business held under Teyame AI Holdings"},{"name":"Nasdaq","relationship":"listing exchange (approval required)"},{"name":"U.S. Securities and Exchange Commission","relationship":"regulator (registration statement review required)"}],"dollarAmounts":[]},"materialImpact":{"score":3,"reasoning":"A strategic separation of HCTI's recently acquired AI businesses via direct listing, with a stock dividend to existing holders — a potentially value-unlocking corporate action for a micro-cap. However, nothing is quantified (no ratio, valuation, or timeline) and completion remains conditional on SEC registration review and Nasdaq approval."},"tickerRelevance":{"others":[],"primary":"HCTI"},"globalImportance":28,"audienceRelevance":30,"eventTypeSecondary":["dividend","restructuring"],"importanceComponents":{"tickerTier":"micro-cap","eventGravity":"subsidiary separation plus planned direct listing","conditionality":"subject to SEC and Nasdaq approval","quantification":"no deal value, ratio, or timeline disclosed","retailAiAngleBoost":"AI spin-off narrative may attract retail attention despite micro-cap tier"}},"event_type":"m_and_a","event_type_secondary":["dividend","restructuring"],"sentiment":"bullish","material_impact_score":3,"narrative":"Healthcare Triangle (Nasdaq: HCTI) signed a separation agreement with its subsidiary Teyame AI Holdings Inc., setting the terms for spinning off the unit via a planned direct listing of Teyame shares on Nasdaq.\n\nIn connection with the separation, HCTI's board approved a stock dividend under which HCTI shareholders of record will receive a minority interest of Teyame AI Holdings common stock, with the record date to be set in future filings.\n\nTeyame AI Holdings contains the AI-powered customer experience businesses Teyame 360 S.L. and Datono Mediación S.L., which HCTI acquired under a January 22, 2026 share purchase agreement. Completion is subject to SEC review of a registration statement and Nasdaq approval; no distribution ratio, valuation, or timeline was disclosed.","key_figures":{},"named_entities":{"people":[],"products":["Teyame AI"],"companies":[{"name":"Healthcare Triangle, Inc.","ticker":"HCTI","relationship":"filer/parent company executing the separation"},{"name":"Teyame AI Holdings Inc.","relationship":"subsidiary to be separated and directly listed on Nasdaq"},{"name":"Teyame 360 S.L.","relationship":"AI-powered customer experience business held under Teyame AI Holdings"},{"name":"Datono Mediación S.L.","relationship":"AI-powered customer experience business held under Teyame AI Holdings"},{"name":"Nasdaq","relationship":"listing exchange (approval required)"},{"name":"U.S. Securities and Exchange Commission","relationship":"regulator (registration statement review required)"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-03T14:38:40.484Z","global_importance":28,"audience_relevance":30,"importance_components":{"tickerTier":"micro-cap","eventGravity":"subsidiary separation plus planned direct listing","conditionality":"subject to SEC and Nasdaq approval","quantification":"no deal value, ratio, or timeline disclosed","retailAiAngleBoost":"AI spin-off narrative may attract retail attention despite micro-cap tier"}},"durationMs":345410,"modelName":"glm-4.7"}}